Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
48.69
+1.19 (+2.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crispr Therapeutics Ag
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
February 29, 2024
The futures for these two beaten-down stocks could be brighter than their recent pasts.
Via
The Motley Fool
Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug
February 27, 2024
Both companies are working on treatments for genetic disorders.
Via
Investor's Business Daily
3 Biotech Stocks Bound to Blast Off By 2029
February 27, 2024
Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years.
Via
InvestorPlace
bluebird bio: How to play LEAPS options for growth and income
February 27, 2024
Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT
Via
MarketBeat
Exposures
Product Safety
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
February 27, 2024
Vertex shares have climbed almost 50% over the past year.
Via
The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
February 23, 2024
Via
Benzinga
Smart Money Is Betting Big In CRSP Options
February 22, 2024
Via
Benzinga
Check Out What Whales Are Doing With CRSP
February 14, 2024
Via
Benzinga
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
February 26, 2024
Latest pharmaceutical trends in the U.S. as drug prices surged 35% in 2023. Uncover insights into the industry's focus on rare diseases, escalating costs, and the impact on FDA-approved drugs.
Via
Benzinga
3 Biotech Stocks to Buy and Hold for the Next 10 Years
February 26, 2024
There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon.
Via
The Motley Fool
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
February 26, 2024
Buy this stock if you're daring, but avoid it for now if you aren't.
Via
The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
February 09, 2024
Via
Benzinga
Three S&P 500 Giants Lead This List Of Stocks Near Buy Points
February 24, 2024
Watch these five stocks, but the market is slightly extended.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Stock Market Rallies To Record High On Nvidia: Weekly Review
February 23, 2024
The stock market rally pulled back to start the week, but roared higher as booming Nvidia earnings and guidance fueled big AI-led gains. The S&P 500 and Dow Jones hit... Read More
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
February 22, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Crispr Reports Its First Profit In 10 Quarters, And Shares Fly Out Of A Buy Zone
February 21, 2024
The company recently gained approval in the U.S. and abroad for its first gene-editing drug.
Via
Investor's Business Daily
Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought
February 20, 2024
These exciting players could deliver explosive growth over time.
Via
The Motley Fool
If You Invested $10,000 in CRISPR Therapeutics in 2019, This Is How Much You Would Have Today
February 19, 2024
It would have been a great move.
Via
The Motley Fool
3 Stocks That Cathie Wood Is Loving Now: February 2024
February 16, 2024
Looking for high-growth opportunities? Here are three Cathie Wood stocks for long-term investors to consider now.
Via
InvestorPlace
What's Going On With Crispr Therapeutics Stock?
February 15, 2024
Crispr Therapeutics shares are trading higher Thursday after Wolfe Research analyst Andy Chen initiated coverage on Crispr Therapeutics with a Peer Perform rating. Crispr Therapeutics' shares have...
Via
Benzinga
Exposures
Product Safety
Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday
February 15, 2024
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Gene therapy: Why does it cost millions for a single treatment?
February 15, 2024
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology.
Via
MarketBeat
Exposures
Product Safety
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
The outlook for growth has made biotech one of the hottest investments of late - and Wall Street sees big comeback gains ahead in these two biotechs.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+
February 13, 2024
CRISPR Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
3 Gene Editing Stocks With Unprecedented Surge Potential
February 13, 2024
While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential.
Via
InvestorPlace
Cathie Wood Has 37% of Her Ark Invest Portfolio Invested in These 7 Stocks
February 12, 2024
The famous investor owns some huge winners -- and big losers, too.
Via
The Motley Fool
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains
February 11, 2024
Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector.
Via
InvestorPlace
3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List
February 09, 2024
These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
February 08, 2024
With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.